EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Intraarterial Infusion of Lidocaine is Superior to the Subcutaneous Injection of Low Molecular Weight Heparin for Improving the Course of Cerulein-Induced Acute Pancreatitis in Rats

Ryszard Antkowiak iD, Lukasz Antkowiak iD, Zbigniew Arent iD, Bogna Drozdzowska iD, Anna Kasperczuk iD, Jacek Bialecki iD, Agnieszka Pietsch-Fulbiszewska iD, Pawel Domoslawski iD, Agata Cieslik-Bielecka iD, Marek Kucharzewski iD

Archivum Immunologiae et Therapiae Experimentalis · 2025

DOI: 10.2478/aite-2025-0012 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archivum Immunologiae et Therapiae Experimentalis, 2025. Verfasst von Ryszard Antkowiak und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Oncologic Surgery, St. Joseph Hospital in Mikolow, Mikolow, Poland. Hauptthemen laut MEDLINE: Lidocaine, Pancreatitis, Heparin, Low-Molecular-Weight, Pancreas. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to determine the efficacy of low molecular weight heparin (LMWH) and lidocaine combined with LMWH for improving the course of acute pancreatitis (AP). A total of 30 rats were divided into three groups: the NaCl group, which received an intraarterial infusion of 0.9% sodium chloride; the Heparin group, which received a subcutaneous injection of LMWH; and the Lidocaine–Heparin group, which received an intraarterial infusion of 1% lidocaine, with subsequent subcutaneous injection of LMWH. AP was triggered using 80 μg/kg body weight of cerulein. Serum amylase and lipase levels were evaluated before induction of AP (measurement 0 – M0), after triggering AP (measurement 1 – M1), 1 h (measurement 2 – M2), 3 h (measurement 3 – M3), and 5 h (measurement 4 – M4) after treatment. After euthanasia, pancreatic tissues were collected for pathological analysis. No intergroup differences in serum amylase and lipase levels were observed between the NaCl and Heparin groups in all post-treatment evaluation points (M2, M3, and M4). Conversely, the Lidocaine–Heparin group showed significantly lower amylase values than the NaCl and Heparin groups in all post-treatment evaluation points. Furthermore, the Lidocaine–Heparin group showed significantly lower lipase values compared with the NaCl group in the first post-treatment evaluation point (M2), as well as compared with the Heparin group in the first (M2) and second (M3) post-treatment evaluation points. No significant intergroup differences were observed in pathological pancreatic tissue evaluation. Subcutaneous injection of LMWH did not impact the natural course of AP. However, the addition of intraarterially administered 1% lidocaine solution significantly reduced the severity of AP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LidocainePancreatitisHeparin, Low-Molecular-WeightPancreasAnimalsRatsAmylasesMaleInjections, SubcutaneousLipaseCeruletideInfusions, Intra-ArterialDisease Models, AnimalAcute DiseaseHumansRats, Wistar

Stichwörter der Autor:innen

AnticoagulationExperimentalMicrocirculationVasodilationcontinuous regional arterial infusion

Substanzen

LidocaineAmylasesLipaseHeparin, Low-Molecular-WeightCeruletide

Autor:innen und Institutionen

  • Department of General and Oncologic Surgery, St. Joseph Hospital in Mikolow, Mikolow, Poland.
  • Department of Pediatric Neurosurgery, Medical University of Silesia in Katowice, Katowice, Poland.
  • Department of Neurosurgery, St. Barbara Regional Hospital and Trauma Center in Sosnowiec, Medical University of Silesia in Katowice, Sosnowiec, Poland.
  • Experimental and Innovative Medicine Centre, University of Agriculture, Krakow, Poland.
  • Department of Pathomorphology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Zabrze, Poland.
  • Faculty of Mechanical Engineering, Institute of Biomedical Engineering, Bialystok University of Technology, Bialystok, Poland.

ORCID-Profile: Ryszard Antkowiak, Lukasz Antkowiak, Zbigniew Arent, Bogna Drozdzowska, Anna Kasperczuk, Jacek Bialecki, Agnieszka Pietsch-Fulbiszewska, Pawel Domoslawski, Agata Cieslik-Bielecka, Marek Kucharzewski

Zitieren

APA

Antkowiak, R., Antkowiak, L., Arent, Z., Drozdzowska, B., Kasperczuk, A., Bialecki, J., Pietsch-Fulbiszewska, A., Domoslawski, P., Cieslik-Bielecka, A., & Kucharzewski, M. (2025). Intraarterial Infusion of Lidocaine is Superior to the Subcutaneous Injection of Low Molecular Weight Heparin for Improving the Course of Cerulein-Induced Acute Pancreatitis in Rats. Archivum Immunologiae et Therapiae Experimentalis. https://doi.org/10.2478/aite-2025-0012

Vancouver

Antkowiak R, Antkowiak L, Arent Z, Drozdzowska B, Kasperczuk A, Bialecki J, et al. Intraarterial Infusion of Lidocaine is Superior to the Subcutaneous Injection of Low Molecular Weight Heparin for Improving the Course of Cerulein-Induced Acute Pancreatitis in Rats. Archivum Immunologiae et Therapiae Experimentalis. 2025. doi:10.2478/aite-2025-0012

BibTeX
@article{Antkowiak2025,
  author = {Antkowiak, Ryszard and Antkowiak, Lukasz and Arent, Zbigniew and Drozdzowska, Bogna and Kasperczuk, Anna and Bialecki, Jacek and Pietsch-Fulbiszewska, Agnieszka and Domoslawski, Pawel and Cieslik-Bielecka, Agata and Kucharzewski, Marek},
  title = {Intraarterial Infusion of Lidocaine is Superior to the Subcutaneous Injection of Low Molecular Weight Heparin for Improving the Course of Cerulein-Induced Acute Pancreatitis in Rats},
  journal = {Archivum Immunologiae et Therapiae Experimentalis},
  year = {2025},
  doi = {10.2478/aite-2025-0012}
}
Kostenlos starten →